Jacob I. Ayers

Jacob I. Ayers

Auto-generated profile, based on publicly available information

Jacob I. Ayers

Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, CA 94158

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ASAmanda N. Sacino
Amanda N. Sacino
MBMieu Brooks
Mieu Brooks
MTMichael A. Thomas
Michael A. Thomas
AMAlex B. McKinney
Alex B. McKinney
SLSooyeon Lee
Sooyeon Lee
BGBenoit I Giasson
Benoit I Giasson
Significance: α-Synuclein (αS) inclusions are a hallmark of many progressive neurodegenerative disorders. Previously, intracerebral injection of exogenous preformed fibrillar αS in mouse models was shown to induce neuronal αS aggregation—a finding that has been interpreted as a prion-like mechanism. We now show that αS inclusion pathology can be induced in the brain and spinal cord of αS transgenic mice by a single peripheral intramuscular injection of αS. The formation of αS inclusions occurred concurrently with the presentation of a motor impairment in mice expressing mutant Ala53Thr human αS. This new model of robust and predictable induction of αS pathology will be especially valuable to further study the pathogenic mechanisms and assessment of therapeutic interventions.

12 April 2021 in Neuron
Verified
Journal Article
Closed access
ELEvan Lester
Evan Lester
FOFelicia K. Ooi
Felicia K. Ooi
NBNadine Bakkar
Nadine Bakkar
JAJacob Ayers
Jacob Ayers
Amanda WoermanAmanda Woerman
Amanda Woerman
RPRoy Parker
Roy Parker

9 December 2015 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
JAJacob I. Ayers
Jacob I. Ayers
SFSusan E. Fromholt
Susan E. Fromholt
VOVeronica M. O’neal
Veronica M. O’neal
JDJeffrey H. Diamond
Jeffrey H. Diamond
DBDavid R. Borchelt
David R. Borchelt

28 September 2014 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
JAJacob I. Ayers
Jacob I. Ayers
SFSusan Fromholt
Susan Fromholt
MKMorgan Koch
Morgan Koch
ADAdam DeBosier
Adam DeBosier
BMBen McMahon
Ben McMahon
DBDavid R. R Borchelt
David R. R Borchelt

17 March 2011 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JAJacob I Ayers
Jacob I Ayers
CSCharles R Schutt
Charles R Schutt
RSRonald A Shikiya
Ronald A Shikiya
AAAdriano Aguzzi
Adriano Aguzzi
AKAnthony Kincaid
Anthony Kincaid
JBJason Bartz
Jason Bartz
Prion strains are characterized by differences in the outcome of disease, most notably incubation period and neuropathological features. While it is established that the disease specific isoform of the prion protein, PrPSc, is an essential component of the infectious agent, the strain-specific relationship between PrPSc properties and the biological features of the resulting disease is not clear. To investigate this relationship, we examined the amplification efficiency and conformational stability of PrPSc from eight hamster-adapted prion strains and compared it to the resulting incubation period of disease and processing of PrPSc in neurons and glia. We found that short incubation period strains were characterized by more efficient PrPSc amplification and higher PrPSc conformational stabilities compared to long incubation period strains. In the CNS, the short incubation period strains were characterized by the accumulation of N-terminally truncated PrPSc in the soma of neurons, astrocytes and microglia in contrast to long incubation period strains where PrPSc did not accumulate to detectable levels in the soma of neurons but was detected in glia similar to short incubation period strains. These results are inconsistent with the hypothesis that a decrease in conformational stability results in a corresponding increase in replication efficiency and suggest that glia mediated neurodegeneration results in longer survival times compared to direct replication of PrPSc in neurons. Prion diseases are a group of infectious fatal neurodegenerative diseases that affect animals including humans. This unique infectious agent is the result of a post-translational conformational change of the normal form of the prion protein, PrPC, to an infectious form of the prion protein, PrPSc. Different strains of the infectious agent result in characteristic incubation periods and neuropathological features within a single host species. These strain-specific differences in disease outcome are likely due to strain-specific conformations of PrPSc, though the mechanisms by which different conformation can affect prion strain properties are not understood. The aim of this study was to investigate the relationship between the biochemical properties of PrPSc to the corresponding neuropathological characteristics of eight hamster-adapted prion strains. Our findings indicate that PrPSc from short incubation period strains were more efficiently replicated, had a more stable conformation, and were observed to be more resistant to clearance from the soma of neurons compared to prion strains with a relatively long incubation period. These results suggest the progression of prion disease is influenced by the balance between replication and clearance of PrPSc in neurons.

1 June 2010 in Journal of Virology
Verified
Journal Article
Open access
PDF file
RSRonald A. Shikiya
Ronald A. Shikiya
JAJacob I. Ayers
Jacob I. Ayers
CSCharles R. Schutt
Charles R. Schutt
AKAnthony Kincaid
Anthony Kincaid
JBJason Bartz
Jason Bartz
Prion strain interference can influence the emergence of a dominant strain from a mixture; however, the mechanisms underlying prion strain interference are poorly understood. In our model of strain interference, inoculation of the sciatic nerve with the drowsy (DY) strain of the transmissible mink encephalopathy (TME) agent prior to superinfection with the hyper (HY) strain of TME can completely block HY TME from causing disease. We show here that the deposition of PrP Sc , in the absence of neuronal loss or spongiform change, in the central nervous system corresponds with the ability of DY TME to block HY TME infection. This suggests that DY TME agent-induced damage is not responsible for strain interference but rather prions compete for a cellular resource. We show that protein misfolding cyclic amplification (PMCA) of DY and HY TME maintains the strain-specific properties of PrP Sc and replicates infectious agent and that DY TME can interfere, or completely block, the emergence of HY TME. DY PrP Sc does not convert all of the available PrP C to PrP Sc in PMCA, suggesting the mechanism of prion strain interference is due to the sequestering of PrP C and/or other cellular components required for prion conversion. The emergence of HY TME in PMCA was controlled by the initial ratio of the TME agents. A higher ratio of DY to HY TME agent is required for complete blockage of HY TME in PMCA compared to several previous in vivo studies, suggesting that HY TME persists in animals coinfected with the two strains. This was confirmed by PMCA detection of HY PrP Sc in animals where DY TME had completely blocked HY TME from causing disease.